These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18634857)

  • 21. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory.
    Higgins GA; Kew JN; Richards JG; Takeshima H; Jenck F; Adam G; Wichmann J; Kemp JA; Grottick AJ
    Eur J Neurosci; 2002 Mar; 15(5):911-22. PubMed ID: 11906533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of opioid receptor-like 1 (ORL1) & mu opioid receptors in the spinal cord of morphine tolerant mice.
    Ray SB; Gupta YK; Wadhwa S
    Indian J Med Res; 2005 Mar; 121(3):194-202. PubMed ID: 15802762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The orphanin receptor agonist RO 64-6198 does not induce place conditioning in rats.
    Le Pen G; Wichmann J; Moreau JL; Jenck F
    Neuroreport; 2002 Mar; 13(4):451-4. PubMed ID: 11930159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain.
    Courteix C; Coudoré-Civiale MA; Privat AM; Pélissier T; Eschalier A; Fialip J
    Pain; 2004 Jul; 110(1-2):236-45. PubMed ID: 15275773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nociceptin/orphanin FQ: role in nociceptive information processing.
    Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
    Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice.
    Walters CL; Godfrey M; Li X; Blendy JA
    Brain Res; 2005 Jan; 1032(1-2):193-9. PubMed ID: 15680959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
    Hawkinson JE; Acosta-Burruel M; Espitia SA
    Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
    Thakker DR; Standifer KM
    Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.
    Zaveri N; Polgar WE; Olsen CM; Kelson AB; Grundt P; Lewis JW; Toll L
    Eur J Pharmacol; 2001 Sep; 428(1):29-36. PubMed ID: 11779034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
    Jhamandas KH; Sutak M; Henderson G
    Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone.
    Kuzmin A; Sandin J; Terenius L; Ogren SO
    J Pharmacol Exp Ther; 2003 Jan; 304(1):310-8. PubMed ID: 12490606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling.
    Hou Y; Tan Y; Belcheva MM; Clark AL; Zahm DS; Coscia CJ
    Brain Res Dev Brain Res; 2004 Jul; 151(1-2):149-57. PubMed ID: 15246701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessment of buprenorphine in conditioned place preference: temporal and pharmacological considerations.
    Tzschentke TM
    Psychopharmacology (Berl); 2004 Feb; 172(1):58-67. PubMed ID: 14615874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
    Mamiya T; Noda Y; Ren X; Nagai T; Takeshima H; Ukai M; Nabeshima T
    J Neural Transm (Vienna); 2001; 108(12):1349-61. PubMed ID: 11810400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of NOP receptors in psychomotor stimulation and locomotor sensitization induced by cocaine and amphetamine in mice.
    Marquez P; Hamid A; Lutfy K
    Eur J Pharmacol; 2013 May; 707(1-3):41-5. PubMed ID: 23524092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications.
    Toll L; Khroyan TV; Polgar WE; Jiang F; Olsen C; Zaveri NT
    J Pharmacol Exp Ther; 2009 Dec; 331(3):954-64. PubMed ID: 19773529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.